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Abstract
Interleukin-10 deficient (IL-10-/-) mice develop chronic T cell-mediated colitis when colonized with
normal commensal bacteria, but germ-free (GF) IL-10-/- mice remain disease-free. Antigen
presenting cells (APC) secrete regulatory cytokines that help determine T lymphocyte activation or
tolerance. CD4+ T cells from the mesenteric lymph nodes of inflamed IL-10-/- mice secrete more
IFNγ and IL-17 when cultured with cecal bacterial lysate-pulsed splenic APC from IL-10-/- mice
than when cultured with normal control APC. GF IL-10-/- APC induce similar IFNγ and IL-17
responses; therefore, the functional difference between normal and IL-10 deficient APC is inherent
to the lack of IL-10 and not secondary to inflammation. Bacterial lysate-pulsed normal APC cultured
with CD4+ cells from colitic IL-10-/- mice or with exogenous IFNγ secrete higher amounts of IL-10
compared to the same APC cultured with naïve T cells. APC enriched for CD11c+ cells are potent
activators of IFNγ and IL-17 production by CD4+ cells from IL-10-/- mice. These APC also produce
IL-12/IL-23 p40 and IL-10. Recombinant IL-10 suppressed and anti-IL-10 receptor antibody
increased IFNγ, IL-17 and IL-12/IL-23 p40 production in bacterial lysate-pulsed APC and plus
CD4+ T cell co-cultures. Taken together, our results show that endogenous IL-10 produced by APC
inhibits responses to commensal bacteria and influences the ability of APC to stimulate IFNγ-
producing effector lymphocytes, which reciprocally, induce IL-10 production by APC. Cytokines
produced by APC are an important determinant of pathogenic versus protective mucosal immune
responses to colonic bacterial stimulation.
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1. Introduction
Inflammatory bowel diseases (IBD) are a constellation of disorders (Crohn’s disease and
ulcerative colitis) characterized by chronic, immune-mediated inflammation that affects the
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digestive tract. Although these are idiopathic conditions, dysregulated cell-mediated immune
responses to nonpathogenic commensal enteric bacteria play a role in the pathogenesis of these
disorders [1,2]. The mucosal immune system maintains a delicate balance; it must be able to
defend against a pathogenic microbial threat yet remain unresponsive to resident bacterial and
dietary antigens and adjuvants. Specifically in Crohn’s disease, loss of tolerance to normal
luminal bacteria is documented by increased antibody production and T lymphocyte responses
to antigens of intestinal bacteria [3-5]. Patients with Crohn’s disease exhibit high mucosal
levels of certain cytokines including IL-23, IL-12, IL-18, IFNγ, IL-17 and TNF [6-12] and
respond to anti-TNF and anti-IL-12/IL-23p40 monoclonal antibody treatment [13,14]. Further
evidence of a role for bacteria in the pathogenesis is the attenuation of symptoms after antibiotic
treatment [15,16].
Rodent models of intestinal inflammation, although not able to fully recapitulate human
disease, provide important insights into the pathogenesis of IBD. First, chronic intestinal
inflammation is T cell dependent; B cells are not required and in certain situations are protective
[17-21]. The profile of cytokines in most models of chronic intestinal inflammation is Th1/
Th17 [17,20,22,23]. IL-23, a heterodimeric cytokine composed of one unique component (p19)
that associates with IL-12p40, has recently emerged as a key inducer of IL-17-mediated
inflammation [23]. However, recent work by Izcue et. al. shows that IL-17 is not required for
development of colitis in all model systems [24]. Second, in most, but not all models, germ-
free (GF), sterile rodents do not develop chronic colitis and continuous exposure to luminal
bacteria is necessary to maintain disease [25-27]. Furthermore, T cells from mice with chronic
intestinal inflammation respond to components of commensal enteric bacteria [17,20,26,
28-31]. Therefore, endogenous nonpathogenic colonic bacteria provide the antigenic and
adjuvant stimulation necessary to maintain intestinal inflammation. This loss of tolerance in
genetically susceptible hosts can be due either to an overly aggressive effector cell activity, to
defective regulatory cell function, or to inadequate response to regulatory signals. Regulatory
cells producing TGFβ and IL-10 mediate tolerance in normal hosts [32].
IL-10 deficient mice spontaneously develop progressive colitis in specific pathogen-free (SPF)
conditions [33], while GF mice develop neither histologic evidence of disease nor immune
activation [25]. GF IL-10 deficient mice develop progressively more aggressive colitis one to
four weeks after colonization with SPF fecal bacteria; however wild-type controls colonized
with the same bacteria do not exhibit colitis or immune activation [25,34]. This clearly
identifies the role of IL-10 in maintaining immunologic tolerance to the normal enteric
microorganisms.
IL-10 is a key immunosuppressive cytokine that acts directly on antigen presenting cells (APC)
to inhibit IL-12 secretion and down regulate the expression of MHC Class II and costimulatory
molecules such as CD80 and CD86 [35]. This direct action on APC indirectly inhibits T cell
activation. IL-10 is produced by multiple cell types, including T cells, dendritic cells (DC),
macrophages, and B cells [35-37]. Regulatory T cells are a well-documented source of IL-10
and have been shown to prevent onset of colitis in several murine models. After transfer of
CD45RBhigh cells, syngeneic scid recipients develop colitis. Cotransfer of CD45RBlo cells,
however, prevents disease [38]. If the CD45RBlo population is derived from IL-10 deficient
mice, this population cannot prevent development of colitis [39]. Furthermore, transfer of IL-10
secreting enteric bacterial-responsive regulatory T cell lines can prevent disease in the C3H/
HeJBir cotransfer model [40]. However, IL-10 regulatory cell function has been described for
other cell populations as well, including DC and B lymphocytes in models of pulmonary or
intestinal inflammation [19,41,42].
Despite the proven importance of IL-10 as an immunosuppressive agent both in vivo and in
vitro, the relative roles of T-cell derived and non-T cell derived IL-10 remain unclear. The
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purpose of this investigation is to explore the ability of intrinsic IL-10 produced by APC versus
CD4+ T lymphocytes to regulate bacterial antigen-induced IFNγ, IL-17, and IL-12/IL-23 p40
responses. We demonstrate that APC-derived IL-10 is an important regulator of T cell
responses to physiologic colonic bacterial stimulation.
2. Materials and Methods
2.1 Mice
IL-10 deficient (IL-10-/-) mice on a 129S6/SvEv background and normal and 129S6/SvEv
(129 wild type) mice were maintained GF in Trexler isolators in the Gnotobiotic Core of the
Center for Gastrointestinal Biology and Disease at the College of Veterinary Medicine, North
Carolina State University, Raleigh, NC. Sterility was confirmed by aerobic and anaerobic fecal
cultures every two weeks. A SPF colony of 129S6/SvEv mice was established from mice
obtained from Taconic Laboratories, Germantown, NY and known to be free of
Helicobacter species. GF→SPF mice used for the source of CD4+ MLN cells were transferred
from GF isolators to the SPF facility at 8-14 weeks of age and euthanized 8 weeks after being
colonized with the fecal contents from the SPF 129S6/SvEv mice described above. The North
Carolina State University Institutional Animal Care and Use Committee (IACUC) approved
all animal protocols.
2.2 Cecal bacterial lysate
Cecal bacterial lysate (CBL) was prepared directly from the cecal contents of 129 wild type
SPF mice according to the protocol of Cong [28]. Briefly, the cecum was isolated, placed in 1
ml of sterile RPMI, and vortexed thoroughly. After removal of the cecal tissue and the addition
of 0.25 ml of MD solution (0.1 mg/ml DNase I, 0.02 mg/ml MgCl2), this mixture was disrupted
by 0.1 mm glass beads in a Mini-bead beater (Biospec Products, Bartlesville OK) for 3 minutes.
After centrifugation, the supernatant was filter-sterilized (0.45 μM filter) and the protein
concentration was measured using a standard assay (Biorad Laboratories, Hercules, CA). Cecal
bacterial lysate was either used immediately after isolation or was aliquoted and frozen at −80°
C.
2.3 Antigen presenting cell (APC) preparation
APC were prepared as previously described [26]. Briefly, spleens were isolated from 129 wild
type or IL-10-/- mice. T cells were depleted by rabbit complement-mediated lysis using anti-
Thy1.2 monoclonal antibody. The resulting population contained less than 6% CD4+ and 1%
CD8+ cells. In select experiments, B220+ and CD11c+ cells were enriched by magnetic
activated cell sorting (MACS). Briefly, T cell depleted splenocytes were incubated with
magnetic beads coupled to antibodies and then passed through the magnetic column (Miltenyi,
Auburn, CA). B220+ cells were negatively selected using anti-CD11c and anti-CD11b
magnetically labeled antibodies and passed through an LD column. CD11c+ cells were
enriched by the following two methods: 1) positive selection using anti-CD11c magnetically
labeled antibodies and passed through an LS column. These cells were pulsed overnight with
an unrelated antigen, keyhole limpet hemocyanin (KLH: Pierce, Rockford, IL), cecal bacterial
lysate at 50 μg/ml, or cultured without antigen in complete medium (RPMI 1640 plus 5% heat
inactivated fetal calf serum, 2 mM L-glutamine, 1 mM sodium pyruvate, 50 μM 2-
mecaptoethanol, and 50 μg/ml gentamicin). 2) cell sorting of spleen cells after incubation with
FITC-labeled anti-mouse CD11c (BD Biosciences, San Diego, CA) using a DakoCytomation
MoFlo High-Speed Cell Sorter (DakoCytomation, Fort Collins, Co). The 129 wild type and
IL-10-/- MoFlo sorted CD11c+ cells were 92.4% and 94.8% CD11c+, respectively. Due to the
low number of CD11c+ APC obtained after MoFlo sorting, the cells were not pulsed overnight.
Instead, 1 × 104 sorted cells were added directly to 96 well plates for co-culture as described
in the following section.
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2.4 CD4+ T cell isolation and stimulation
CD4+ cells were isolated and stimulated as previously described [26]. GF IL-10-/- mice were
moved to SPF housing conditions and colonized with commensal microorganisms from 129
wild type mice that were free of Helicobacter species. After 8-14 weeks, the mesenteric lymph
nodes (MLN) were isolated and single cell suspensions were prepared. The CD4+ T cells were
separated by negative selection using MACS as follows: MLN cells were incubated with
magnetic beads coupled to anti-CD8 and anti-B220 antibodies (Miltenyi), and passed through
and LD column allowing CD4+ cells to be enriched. The enriched cell population was greater
than 95% CD4+. APC were collected after overnight pulsing and washed twice to remove
soluble antigens and other bacterial products. APC were cultured at 3 × 105 cells per well with
CD4+ cells at 2 × 105 cells per well in flat bottom 96 well plates (Costar 3595). The T cell
number was selected based on our previously published results showing maximal responses
using 2 × 105 CD4+ cells per well in 200 μl [43]. In preliminary experiments for the current
studies, in which we titrated APC numbers, we obtained higher amounts of IFN-γ and IL-17
produced by CD4+ T cells co-cultured with 3 × 105 compared to 1 × 105 APC per well (200
μl), and therefore we used 3 × 105 cells per well for co-culture (data not shown). For co-culture
with MoFlo sorted CD11c+ APC, cecal bacterial lysate (50 μg/ml) was added directly to wells
containing 1 × 104 CD11c+ cells plus 2 × 105 highly enriched CD4+ T cells obtained by negative
selection with magnetic beads coated with anti-CD8, anti-B220, anti-CD11b, and anti-CD11c.
The resulting cell population was greater than 98% CD4+ and did not produce IFN-γ in cultures
containing cecal bacterial lysate without APC (data not shown). In selected experiments
recombinant murine IFNγ (R&D Systems, Minneapolis, MN), recombinant murine IL-10
(PeproTech, Rocky Hill, NJ), anti-IL-10 receptor antagonistic antibody [44, clone 1B1.3a, BD
Biosciences], anti-mouse IFN-γ (clone R4-6A2, BD Biosciences), or rat IgG1 isotype control
(clone R3-34, BD Biosciences) was added during the APC pulse or during the APC/CD4+
lymphocyte cocultures. Triplicate supernatants were collected at 72 hours.
2.5 Flow cytometry
Cells were incubated for 30 minutes at 4°C with fluorochrome-conjugated antibodies,
including anti-CD4, CD8, B220 (Caltag, Burlingame, CA), CD11b, CD11c, CD40, CD45RB,
MHC Class II (I-Ab), CD80, and CD86, (BD Biosciences). Cells were washed and then
analyzed on a FACScan (Becton Dickinson, San Jose, CA).
2.6 Cytokine measurement
Commercially available monoclonal capture and detection antibodies specific for mouse
IFNγ and IL-12/IL-23 p40 were used in ELISA protocols as described [26]. To measure IL-17,
we used clone TC11-18H10 for capture and biotin-labeled clone TC11-8H4.1 for detection
(both from BD Biosciences). For the IL-23 ELISA, we used anti-IL-23 p19, clone G23-8
(eBioscience, San Diego, CA) as capture antibody and biotin-labeled anti-IL-12/IL-23 p40,
clone C17.8 (BD Biosciences) for detection. To measure IL-12 p70 heterodimer, we used clone
9-A5 as capture antibody and biotin labeled anti-IL-12/IL-23 p40 clone C17.8 for detection
(both from BD Biosciences). For the IL-10 ELISA, we used JES5-2A5 as the capture antibody
and biotin-labeled SXC-1 as the detection antibody (both from BD Biosciences). The
background of the IL-10 ELISA ranges from 10 to 100 pg/ml. Backgrounds are negligible for
all other ELISAs. Limits of detection are approximately 5 pg/ml for each cytokine.
2.7 Statistical analysis
Data were analyzed using the Student’s t test and p values of less than 0.05 were considered
significant.
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3.1 Cecal bacterial lysate-pulsed APC from IL-10-/- mice stimulate secretion of higher
concentrations of IFNγ and IL-17 by CD4+ MLN T lymphocytes than do APC from wild type
mice
IL-10-/- mice, born in GF housing conditions and then moved to SPF housing as adults
(GF→SPF), consistently developed severe colitis (blinded histology score of cecum is 3.8 ±
0.2 on a 0-4 scale). The MLN from the inflamed GF→SPF IL-10-/- mice were grossly enlarged,
containing 4-10 times the number of total cells compared to MLN from normal mice (89.1 ×
106 versus 8.4 × 106 cells per mouse, 3 mice per group). CD4+ lymphocytes from the MLN of
GF or SPF wild type controls and from GF or GF→SPF IL-10-/- mice were isolated for
stimulation in vitro with cecal bacterial lysate-pulsed splenic APC from SPF IL-10-/- or normal
129 wild type mice. Because GF IL-10-/- mice do not develop colitis (blinded histology score
of cecum was 0.12 ± 0.05 on a 0-4 scale), the MLN were not grossly enlarged and the number
of cells was no different from GF 129 wild type mice (18.6 × 106 for GF IL-10-/- versus 16.7
× 106 cells per mouse for GF 129 wild type, 4 mice per group). When cecal bacterial lysate-
pulsed APC from SPF IL-10-/- mice were used to stimulate GF→SPF IL-10-/- CD4+
lymphocytes, the amounts of detectable IFNγ and IL-17 were 3-5 fold higher than IFNγ and
IL-17 in cultures of CD4 cells stimulated with bacterial lysate-pulsed APC from 129 wild type
mice (Fig. 1a, 1b). In addition, CBL-pulsed APC from IL-10-/- mice induced low but detectable
IFNγ and IL-17 responses in both SPF and GF 129 CD4+ lymphocytes and in GF naïve IL-10-/-
CD4+ cells. For each source of CD4+ T cells, APC from IL-10-/- mice induced significantly
greater IFNγ and IL-17 than did wild type APC. This ability of IL-10-/- APC to stimulate
IFNγ and IL-17 secretion supports the hypothesis that IL-10-/- APC have the capacity to induce
pathogenic CD4+ lymphocyte responses to commensal cecal bacteria and to skew T cell
responses. In contrast, bacterial lysate-pulsed APC from IL-10 replete mice did not stimulate
IFNγ or IL-17 secretion by CD4+ lymphocytes from the SPF wild type mice or from the naïve
GF wild type or IL-10-/- mice.
3.2 IL-12/IL-23 p40 is produced by cecal bacterial lysate-pulsed IL-10-/- APC
Cecal bacterial lysate-pulsed APC from wild type mice did not secrete detectable IL-12/IL-23
p40 under any of our culture conditions (Fig. 1c). However, bacterial lysate-pulsed APC from
IL-10-/- mice secrete this molecule even when cultured without T cells (905 ± 47 pg/ml). IL-12/
IL-23 p40 secretion by APC from IL-10-/- mice was not spontaneous because none was
detected in supernatants of APC from IL-10-/- mice pulsed with KLH (data not shown).
IL-10-/- APC cultured with CD4+ lymphocytes from GF→ SPF IL-10-/- colitic mice produced
significantly more IL-12/IL-23 p40 than did APC in cultures containing CD4+ T cells from
GF mice and SPF 129 wild type mice. The ability of cecal bacterial lysate to stimulate IL-12/
IL-23 p40 production by APC from IL-10-/- mice indicates that antigens and adjuvants
normally present in the mouse cecum activate APC from IL-10-/- mice but not APC from IL-10
replete mice. Neither the IL-12 p70 nor the IL-23p19/p40 heterodimer were detectable in these
culture supernatants.
3.3 IL-10 production by cecal bacterial lysate-stimulated wild type APC is enhanced by
culture with IL-10-/- CD4+ T cells from colitic mice
Because both APC and CD4+ lymphocytes can produce IL-10, using APC and CD4+
lymphocytes from 129 wild type and IL-10-/- mice allowed us to determine the source of IL-10
produced in the mixed co-cultures. Cecal bacterial lysate-pulsed APC from wild type mice
secreted IL-10 even when cultured without T cells (Fig. 1d). The addition of CD4+ lymphocytes
from GF→ SPF IL-10-/- colitic mice significantly increased the amount of IL-10 produced by
bacterial lysate-pulsed 129 wild type APC compared to IL-10 in cultures containing wild type
APC plus naïve T cells. CD4+ lymphocytes from SPF wild type mice also produced IL-10 and
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their contribution could be seen in cultures that contain IL-10-/- APC (Fig. 1d). The ability of
wild type APC to produce IL-10 in response to CD4+ T cells from an inflamed mouse supports
the hypothesis that APC from normal hosts have the capacity to regulate inflammation.
3.4 APC from GF and from SPF IL-10-/- mice stimulate similar levels of IFNγ and IL-17
In our in vitro culture system, GF IL-10-/- CD4+ lymphocytes produced low amounts of
IFNγ and IL-17 that were comparable to both GF and SPF IL-10 replete CD4+ lymphocytes
(Fig 1a, 1b). All three sources of CD4+ cells induced a similar amount of IL-12/IL-23 p40
production by APC (Fig 1c). Therefore, the high levels of IFNγ and IL-17 produced by
GF→SPF IL-10-/- CD4+ MLN lymphocytes and their ability to induce elevated IL-12/IL-23
p40 are not directly caused by their IL-10 deficiency but instead this response is either
secondary to their activation by in vivo exposure to enteric bacteria or secondary to chronic
inflammation. We therefore designed experiments to determine whether or not differences in
cytokine production by the IL-10-/- APC were also secondary to inflammation or in vivo
bacterial activation. For this analysis, we compared 129 wild type and IL-10-/- APC isolated
from GF and from SPF mice. GF and SPF IL-10-/- APC, pulsed with cecal bacterial lysate,
induced production of equivalent amounts of IFNγ and IL-17 by CD4+ lymphocytes from
GF→SPF IL-10-/- mice (Fig. 2a, 2b), showing that in vivo activation was not necessary for
enhanced stimulation of either cytokine by in vitro bacterial lysate-activated IL-10-/- APC.
Consistent with previous results, bacterial lysate-pulsed 129 wild type APC stimulated
production of significantly less IFNγ and IL-17 by activated IL-10-/- MLN CD4+ T cells than
did IL-10-/- APC (Fig 2a, 2b).
3.5 APC from GF mice produce low levels of IL-12/IL-23 p40 and high levels of IL-10
Both GF and SPF IL-10-/- bacterial lysate-pulsed APC produced detectable levels of IL-12/
IL-23 p40 (Fig. 2c). However, significantly more IL-12/IL-23 p40 was detected in cultures of
IL-10-/- CD4+ lymphocytes stimulated with SPF IL-10-/- APC compared to cultures stimulated
with GF IL-10-/- APC (2559 ± 361 v 1405 ± 245, p<0.001). These results indicate that in
vivo exposure to enteric bacteria or the in vivo inflammatory milieu enhances the ability of
cecal bacterial lysate-pulsed APC to produce IL-12/IL-23 p40 when co-cultured with IL-10-/-
CD4+ from colitic mice. Nonetheless, while GF IL-10-/- APC secrete less IL-12/IL-23 p40
than do SPF IL-10-/- APC, both induce equivalent amounts of IFNγ and IL-17 production by
IL-10-/- CD4+ lymphocytes from mice with colonic inflammation (Fig. 2a, 2b). Thus, the
difference between the ability of 129 wild type and IL-10-/- APC to induce both of these
cytokines is inherent to the lack of IL-10 and not secondary to chronic inflammation. APC
obtained from GF and SPF 129 wild type mice produce equivalent amounts of IL-10 in response
to cecal bacterial lysate (Fig. 2d). IL-10 production by GF and SPF APC is significantly
upregulated when co-cultured with CD4+ lymphocytes from inflamed GF→SPF IL-10-/- mice.
As noted in Fig. 1d, 129 wild type CD4+ MLN T cells secreted small amounts of IL-10 when
cultured with bacterial lysate-pulsed IL-10-/- APC. These results demonstrate that components
of cecal contents stimulate IL-10 production by APC and that activated CD4+ MLN cells can
augment IL-10 production by APC from normal hosts.
3.6 IFNγ addition to cecal bacterial lysate-pulsed APC augments IL-10 production by 129 wild
type APC but not IL-12/IL-23 p40 production by IL-10-/- APC
We then sought to determine whether IFNγ was responsible for the increased IL-10 secretion
induced in 129 wild type APC. APC were pulsed overnight with either bacterial lysate or KLH
and then cultured either with CD4+ lymphocytes from the MLN of inflamed IL-10-/- mice or
with varying concentrations of recombinant murine IFNγ. The addition of IFNγ in
concentrations equivalent to those produced by bacterial lysate-pulsed APC/CD4+ MLN
lymphocyte cultures, induced IL-10 production by bacterial lysate-pulsed but not by KLH-
Albright et al. Page 6













pulsed 129 wild type APC (Fig. 3a). Recombinant IFNγ (40 ng/ml) induced APC to secrete a
comparable amount of IL-10 as found in co-cultures with activated CD4+ MLN cells from
IL-10-/- mice. Therefore, activation by cecal bacterial lysate stimulation and IFNγ are both
necessary for the induction of IL-10 by APC while signals provided by contact with CD4+
lymphocytes are not required. APC cultured without exogenous antigen functioned similarly
to KLH-pulsed APC in all experiments (data not shown).
Further evidence to support a role for IFNγ in the induction of IL-10 in APC-T cell co-cultures
was obtained in experiments using anti-IFNγ antibody. Although the effect is modest, we
observed a significant reduction in the amount of IL-10 detected in supernatants of cecal
bacterial lysate pulsed APC co-cultured with SPF IL-10-/- CD4+ T cells in the presence of
2500 ng/ml anti-IFNγ antibody compared to an equivalent amount of isotype control antibody
(Fig. 3b).
Bacterial lysate-pulsed IL-10-/- APC produced dramatically more IL-12/IL-23 p40 than did
KLH-pulsed IL-10-/- APC (Fig 3c). However, in contrast to IL-10 production, the addition of
recombinant IFNγ to bacterial lysate-pulsed IL-10-/- APC did not significantly increase IL-12/
IL-23 p40 production over this baseline, yet bacterial lysate-pulsed IL-10-/- APC produced
even higher amounts of IL-12/IL-23 p40 when cultured with CD4+ MLN lymphocytes from
GF→SPF IL-10-/- mice. Therefore, cecal bacterial lysate stimulation and IFNγ do not provide
the necessary signals for the full induction of IL-12/IL-23 p40 by APC. It is likely that either
contact with activated CD4+ lymphocytes or molecules other than IFNγ enhanced IL-12/IL-23
p40 production by bacterial lysate-pulsed IL-10-/- APC.
3.7 Elevated proportion of CD11c+ cells in the spleens of IL-10-/- mice
We next analyzed the phenotype of the spleen cells from SPF 129 wild type mice and from
SPF colitic IL-10-/- mice that were used as the source of APC after the depletion of T
lymphocytes. The T cell depleted splenocytes from 129 wild type mice contained higher
proportions of B220+ cells (129 wild type v IL-10-/-; 89.2 ± 2.8% v 82.7 ± 3.5%, p < 0.05),
while the IL-10-/- spleens contained a reciprocally higher percentage of CD11c+ cells (129
wild type v IL-10-/-; 4.8 ± 0.6% v 7.8 ± 1.5%, p < 0.01). Likewise, IL-10-/- T cell depleted
spleens contained more CD11b single positive cells (129 wild type v IL-10-/-; 1.6 ± 0.4% v
6.6 ± 0.9% p < 0.02) and CD11b/CD11c double positive cells (129 wild type v IL-10-/-; 2.0 ±
0.3% v 3.6 ± 0.6%, p < 0.1). In addition, we evaluated the expression of the costimulatory
molecules on wild type and IL-10-/- APC after pulsing overnight with cecal bacterial lysate.
A higher percentage of bacterial lysate-pulsed IL-10-/- APC expressed CD86 compared to
bacterial lysate-pulsed wild type APC. The difference in CD86 expression was consistently
observed in four separate experiments (71.4 ± 4.1% v 56.7 ± 4.6%, p < 0.005). No reproducible
differences in CD40, CD80 and MHC Class II expression were noted between wild type and
IL-10-/- APC, and no significant differences were seen between wild type and IL-10-/- APC
pulsed with the control protein KLH (data not shown).
A small percentage of CD4+ cells remained after T cell depletion (<5%), although this
population was greatly diminished after overnight pulsing. Therefore, the composition of the
two sources of APC is phenotypically distinct.
3.8 Percentage of CD11c cells in APC correlates with increased IFNγ, IL-17, IL-12/IL-23 p40,
and IL-10 production
To determine which cell type was primarily responsible for APC activity, the APC preparations
were enriched for B220+ cells or for CD11c+ cells as described in Materials and Methods. The
percentage of CD11c+ cells, determined by flow cytometry after overnight pulsing, is indicated
(Fig. 4). As the percentage of CD11c+ cells increased in the culture, the induction of IFNγ and
Albright et al. Page 7













IL-17 production by IL-10-/- CD4+ lymphocytes was enhanced for both 129 wild type and
IL-10-/- APC, although IL-10-/- APC were consistently more efficient (Fig. 4a, 4b). As shown
in Figures 1b and 2b, unseparated 129 wild type APC did not produce detectable IL-12/IL-23
p40 under any culture conditions. Although 129 wild type APC did produce small amounts of
IL-12/IL-23 p40 when enriched for CD11c+ cells, the amount was the same when the APC
were cultured with either 129 wild type CD4+ T lymphocytes or with activated IL-10-/-
CD4+ T lymphocytes (Fig 4c, 383 ± 5 v 355 ± 11 pg/ml). For IL-10-/- APC, as the percentage
of CD11c+ cells increased, the production of IL-12/IL-23 p40 significantly increased and
production of this molecule was enhanced further by the presence of activated IL-10-/-
CD4+ T lymphocytes (Fig. 4c). Conversely, the depletion of CD11c+ cells and the enrichment
of B220+ cells eliminated most of the IL-12/IL-23 p40 from the IL-10-/- APC cultures (Fig.
4c). The production of IL-10 in co-cultures of IL-10-/- APC with 129 wild type CD4+
lymphocytes remained fairly constant as the percentage of CD11c+ cells increased, reflecting
IL-10 production by the wild type 129 CD4+ T lymphocytes (Fig. 4d). IL-10 detected in cultures
of 129 APC with 129 CD4+ lymphocytes also remained constant as the percentage of
CD11c+ cells increased, although the source of the IL-10 could not be identified. However,
the production of IL-10 in cultures of wild type 129 APC with IL-10-/- CD4+ lymphocytes
increased significantly as the percentage of CD11c+ cells increased in the APC population.
Because only the wild type 129 APC in these cultures can produce IL-10, the APC can be
identified as the source of the IL-10. As in the cultures containing unseparated APC, 129 APC
cocultured with IL-10-/- CD4+ T lymphocytes from colitic mice secreted significantly more
IL-10 than did 129 APC cultured with 129 CD4+ T lymphocytes. These results indicate that
CD11c+ cells provide the primary source for IL-12/IL-23 p40 and IL-10 secretion following
cecal bacterial lysate stimulation and are the most active APC governing CD4+ cell stimulation.
It should be noted that neither IL-12 p70 nor IL-23 p19/p40 were detectable in these culture
supernatants. Either these two molecules are not secreted, or they are produced in very low
amounts, or utilized during the 3 day incubation period.
For a more direct analysis of capacity of CD11c+ cells to function as APC, we used high speed
cell sorting to obtain purified CD11c+ cells from the spleens of SPF 129 and IL-10-/- mice.
Due to low yield of this cell type, especially from spleens of wild type mice, we did not pulse
the cells overnight. Instead, we co-cultured CD11c+ cells (1 × 104 per well) together with cecal
bacterial lysate and IL-10-/- MLN cells highly enriched for CD4+ cells by elimination of cells
expressing CD11b, CD11c, B220 and CD8 as described in Material and Methods. This
population of enriched CD4+ cells did not respond to bacterial lysate in the absence of APC
(data not shown). Even though we detected much lower levels of IFNγ and IL-17 compared to
amounts in supernatants of co-cultures shown in Figure 4, probably as a result of using 30-fold
lower numbers of APC, the results presented in Figure 5 confirm that CD11c+ cells are potent
APC that are capable of producing IL-12/IL-23 p40 when cultured with cecal bacterial lysate.
IL-10 was undetectable in these supernatants, most likely due to the low number of CD11c+
APC. It should be noted that the differences in the ability of APC from IL-10-/- vs wild type
mice to induce of CD4+ T cell responses are less dramatic when CD11c+ cells are enriched
(Fig 4a, Fig 4b, Fig 5a, and Fig 5b) compared to APC after T cell depletion only (Fig. 2a, Fig.
2b).
3.9 Recombinant murine IL-10 added to cultures containing IL-10-/- APC and IL-10-/- CD4+
lymphocytes reduced the production of IFNγ, IL-17, and IL-12/IL-23 p40
To confirm that IL-10 inhibits cytokine production in our model system, we next added
exogenous recombinant murine IL-10 to IL-10-/- APC during the overnight pulse with cecal
bacterial lysate. The APC were washed as usual to remove any excess bacterial components
and then additional recombinant IL-10 was added directly to the co-cultures of IL-10-/- APC
and IL-10-/- CD4+ T lymphocytes from colitic mice. We chose 500 and 50 pg/ml to
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approximate the amounts of IL-10 we measured in co-cultures of 129 wild type APC plus
IL-10-/- CD4+ T lymphocytes. As the amount of IL-10 added (from 0 to 500 pg/ml) was
increased during pulsing of APC with cecal bacterial lysate or independently during the APC
plus CD4+ T cell co-cultures, the secretion of IFNγ by the CD4+ lymphocytes decreased (Fig.
6a). Likewise, addition of IL-10 inhibits IL-17 production (Fig. 6b). In parallel, as the amount
of IL-10 was increased during the APC pulse and during co-culture, the production of IL-12/
IL-23 p40 also decreased (Fig. 6c). Thus, the introduction of IL-10 to the in vitro cultures can
alter the function of the IL-10-/- APC to approximate the function of the wild type APC.
Inhibition is optimal when IL-10 is present both during the pulsing step with cecal bacterial
lysate as well as the co-culture with CD4+ MLN cells, but significantly decreased IL-12/IL-23
p40, IFNγ, and IL-17 secretion are noted at either pulsing or co-culture.
3.10 Anti-IL-10 receptor antibody added to wild type 129 APC plus IL-10-/- CD4+ lymphocyte
cultures increased the production of IFNγ, IL-17, and IL-12/IL-23 p40
We next evaluated the effects of endogenous IL-10 by blocking its activity with anti-IL-10
receptor antibody (anti-IL-10R). This reagent or the isotype control was added to 129 wild type
APC at 30 μg/ml during the overnight pulse with cecal bacterial lysate. The APC were washed
as usual to remove excess bacterial components and then additional anti-IL-10R or isotype
control antibody was added directly to the co-cultures of APC plus IL-10-/- CD4+ T
lymphocytes from colitic mice. The anti-IL-10R used for this study acts as an antagonistic
antibody blocking the binding and subsequent signaling by IL-10. Adding anti-IL-10R either
during the pulse or the APC/CD4+ cell co-culture increased the production of IFNγ (Fig 7a)
and IL-17 (Fig 7b) by the IL-10-/- CD4+ T lymphocytes. Likewise, adding anti-IL-10R either
during the pulse or the co-culture increased the production of IL-12/IL-23 p40 by the wild type
129 APC (Fig 7c). When anti-IL-10R was added to both the pulse and the culture, the secretion
of IL-12/IL-23 p40 by the 129 APC was elevated compared to 129 APC cultured with the
isotype control. Blocking the IL-10 receptor resulted in an increase of IL-10 in the cultures
(Fig 7d) presumably due to elevated IFNγ levels as show in Fig 7a. Thus, blocking IL-10 during
the in vitro cultures can alter wild type APC function to approximate the function of the IL-10-/-
APC. As with the recombinant IL-10 addition experiments, blocking IL-10 signaling with anti-
IL-10R antibody was effective during APC pulsing with bacterial lysate and during APC/
CD4+ lymphocyte co-culture, but was most effective when applied during both pulsing and
co-culture.
4. Discussion
IL-10 plays a critical role in maintaining the balance between immune activation and tolerance.
Insufficient or absent IL-10 leads to overzealous immune activation and chronic inflammation
while excess IL-10 leads to immune suppression and increased susceptibility to infection
[35,36,45]. In this study we show that endogenous IL-10 from APC is a key regulator of both
innate and acquired immune responses to physiologic enteric bacterial stimuli. CD4+ T cells
from inflamed IL-10 deficient mice secreted more IFNγ and IL-17 when cultured with cecal
bacterial lysate-pulsed IL-10 deficient APC than when cultured with 129 wild type APC.
Moreover, IL-10 deficient APC secreted high levels of IL-12/IL-23 p40 when pulsed overnight
with cecal bacterial lysate; this secretion was enhanced by co-culture with IFNγ producing
CD4+ T cells from IL-10 deficient mice. APC from normal mice, however, did not secrete
detectable levels of IL-12/IL-23 p40 after bacterial lysate pulsing. Instead, these APC
responded to activated CD4+ T cells or to added recombinant IFNγ by secreting higher amounts
of IL-10. Blockade of IL-10 signaling in normal APC or the addition of physiologic amounts
of recombinant IL-10 to IL-10 deficient APC mimicked the function of IL-10 deficient or
normal wild type APC, respectively.
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Several important experiments highlight the role of IL-10 from regulatory T cell cells in the
prevention of colitis. For example, the cotransfer of CD45RBlo cells from IL-10 deficient mice
fails to prevent chronic colitis in the CD45RBhigh T cell transfer model [39]. In separate
experiments, colitis induced by IFNγ-producing bacterial antigen specific CD4+ clones was
prevented by co-transfer of IL-10-producing clones [40]. These and other studies clearly
identify T cells as one source of IL-10 with the ability to regulate inflammation. However, our
results demonstrate that IL-10 produced by bacterial antigen and adjuvant-pulsed APC
regulates IFNγ and IL-17 production by bacterial antigen-responsive CD4+ T cells in vitro.
We have extended these observations by evaluating intestinal inflammation in an adoptive
CD4+ cell transfer system using Rag2-/-recipients crossed with either IL-10-/- or IL-10+/+
mice [46]. Our results clearly show that IL-10 production by antigen presenting cells but not
by CD4 T cells plays a dominant role in preventing colitis. Also, recent studies published by
Gu et al confirm that IL-10 is a potent inhibitor of IL-17 and of the transcription factor
RORγt that is critical for the development of IL-17 producing cells [47].
IL-10 deficient mice develop chronic, immune mediated colitis in an SPF environment but
inflammation does not develop under GF conditions [25]. CD4+ MLN T cells from GF→ SPF
IL-10 deficient mice with colitis secrete IFNγ and IL-17 in response to endogenous enteric
bacterial antigens processed and presented by APC from both IL-10 deficient and normal mice.
CD4+ T cells isolated from GF mice are predominantly naïve and CD4+ T cells from GF IL-10
deficient mice did not secrete IFNγ when stimulated by cecal bacterial lysate-pulsed 129 wild
type APC. Thus the naïve IL-10 deficient T cells from the MLN of GF mice are functionally
distinct from IL-10 deficient T cells of SPF mice, which are activated in vivo, presumably by
exposure to IL-10 deficient APC that have processed commensal enteric bacterial antigens.
Once activated, these IL-10 deficient CD4+ MLN cells continued to produce IFNγ and IL-17
when exposed ex vivo to bacterial lysate-pulsed APC, even in the presence of IL-10 either
secreted by wild type APC or added to IL-10 deficient APC. In contrast, APC isolated from
either GF or SPF IL-10 deficient mice are functionally similar. Both cell populations, after
overnight pulsing with cecal bacterial lysate, stimulated CD4+ IL-10 deficient T cells to secrete
high amounts of IFNγ and IL-17, although GF APC secreted less IL-12/IL-23 p40 compared
to SPF APC. Therefore, functional differences between IL-10 deficient APC and 129 APC are
due to the presence or absence of endogenous IL-10 and are not dependent on in vivo activation
by commensal bacteria or proinflammatory cytokines in the inflamed colon.
Normal wild type SPF mice maintain immune tolerance to their commensal microbiota. When
MLN CD4+ T cells from GF or SPF wild type mice were cultured with bacterial lysate-pulsed
wild type APC, IL-10 but not IFNγ, IL-17 or IL-12/IL-23 p40 was produced. The observed
IL-10 was most likely secreted by both APC and CD4+ T cells. However, despite in vivo
tolerance to enteric bacteria, CD4+ T cells from normal mice could be activated in vitro by
bacterial lysate-pulsed IL-10 deficient APC to secrete IFNγ and IL-17, showing that lack of
IL-10 production by APC can reverse tolerance. One possible explanation involves the
increased expression of CD86 by IL-10 deficient APC [48]. Other cellular components that
may also contribute to the potency of IL-10 deficient APC include the chemokines, cytokines,
and additional signaling molecules identified in a proteomic analysis of Chlamydia antigen-
activated dendritic cells from IL-10 deficient mice [49].
The importance of intrinsic IL-10 in suppressing pathologic mucosal immune responses to
commensal enteric bacteria is confirmed by similar phenotypes of colitis with either IL-10
deletion or disruption of components of the IL-10 signaling pathway. Deleting class II cytokine
receptor-4 (CRF2-4), a subunit of the IL-10 receptor, or the selective deletion of Stat3 in
macrophages and neutrophils leads to colitis dominated by a Th1 profile of cytokines [50,
51]. Similarly, in our in vitro culture system, the addition of neutralizing anti-IL-10R antibody
both during the pulse and the co-culture of wild type 129 APC with CD4+ T cells significantly
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increased IFNγ and IL-17 secretion by IL-10-/- CD4+ T cells as well as the production of IL-12/
IL-23 p40. Conversely, when physiologically relevant amounts of recombinant IL-10 were
added both during the pulse and the co-culture with CD4+ T cells, the IL-10 deficient APC
functioned similarly to 129 wild type APC: IL-12/IL-23 p40 secretion was eliminated while
the induction of IFNγ and IL-17 in CD4+ MLN cells from IL-10 deficient mice with colitis
was significantly reduced. Importantly, recombinant IL-10 added only during the overnight
APC pulse also significantly reduced IL-12/IL-23 p40, IFNγ, and IL-17 production by co-
cultured IL-10 deficient APC and CD4+ T cells, although not to levels observed in supernatants
of co-cultures containing wild type 129 APC.
An important aspect of our study is the observation that activated IL-10-/- CD4+ MLN cells
stimulated IL-10 secretion by wild type 129 APC. This upregulation of IL-10 appeared to be
induced, at least in part, by IFNγ as demonstrated by the ability of relevant concentrations of
recombinant IFNγ, in the absence of CD4+ MLN cells, to induce IL-10 secretion by bacterial
lysate-pulsed APC. We also demonstrated a modest reduction in IL-10 secretion in
supernatants of CD4+ IL-10-/- MLN cells stimulated with bacterial lysate-pulsed 129 APC in
the presence of anti-IFNγ antibody. It is possible that the antibody does not effectively block
IFN-γ mediated signaling or that IFN-γ is not the sole inducer of IL-10 in this system.
Nevertheless, this response of normal APC to proinflammatory cytokines could provide an
important mechanism of downregulating inflammatory responses to restore tolerance to
commensal bacteria and to prevent chronic inflammation after a self-limited stimulus, such as
clearance of a bacterial pathogen. In this context, it is of interest that IL-10 is capable of
protecting epithelial cells from IFN-γ mediated damage [52].
Enrichment of B220+ cells (B lymphocytes) or CD11c+ cells (dendritic cells) indicated that
CD11c+ cells were primarily responsible for bacterial lysate-stimulated APC-induced cytokine
production. IL-10, IL-12/IL-23 p40 and induction of IFNγ and IL-17 increased proportionally
with the percentage of CD11c+ cells. Splenic APC from colitic SPF IL-10 deficient mice
contained approximately twice as many CD11c+ cells relative to spleen cells from 129 wild
type mice., Although enrichment of CD11c+ cells reduced the difference between the amounts
of cytokines produced in co-cultures containing IL-10 deficient APC compared to wild type
APC, differential responses were not merely a consequence of different CD11c+ cell numbers,
since different cytokine profiles were also observed in co-cultures containing equivalent
proportions of wild type and IL-10 deficient CD11c+ APC.
Previous reports have shown IL-10 production by B lymphocytes, macrophages, and dendritic
cells [19,31,41,45,49,53]. Recently, results published by Monteleone et al demonstrated IL-10
but not IL-12p70 production by TLR ligand-activated dendritic cells derived from the intestinal
lamina propria [54]. These results are consistent with our previous observations that IL-10
deficient bone marrow-derived dendritic cells produce much higher concentrations of IL-12/
IL-23 p40 in response to LPS than do dendritic cells from wild type mice [53]. In our current
study, bacterial lysate pulsed APC enriched for CD11c+ cells produced 2 fold more IL-10 than
did pulsed APC enriched for B220+ cells in co-cultures containing CD4+ IL-10 deficient cells.
Similarly, Iwasaki and Kelsall demonstrated that a CD11c+CD11b+ enriched population of
splenocytes upregulated IL-10 production after stimulation with Staph aureus, Cowan’s strain
(SAC) plus recombinant IFNγ [55]. In contrast, IL-10 producing B cells are dominant in a
model of arthritis that could be prevented by transfer of B cells, activated in vitro with antigen
and anti-CD40 antibody, from normal but not IL-10 deficient mice [56]. In SPF HLAB27
transgenic rats that spontaneously develop colitis, B cells are the major source of IL-10 in in
vitro cultures of MLN cells stimulated with cecal bacterial lysate [31]. In summary, our results
strongly implicate endogenous IL-10 production by APC as a key regulator of tolerogenic
innate and acquired mucosal immune responses to commensal intestinal bacteria. Moreover,
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induction of IL-10 secretion by APC, especially CD11c+ cells, in response to IFNγ could be
an important determinant of the restoration of homeostasis after immune activation.
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Cytokine production from co-cultures of CD4+ T lymphocytes isolated from MLN of either
noncolitic mice (GF 129, GF IL-10-/-, SPF 129) or colitic mice (GF→SPF IL-10-/-) stimulated
by cecal bacterial lysate-pulsed APC from either wild type 129 (black bars) or IL-10-/- mice
(grey bars). Supernatants were harvested at day 3 and assayed by ELISA for (a) IFNγ, (b)
IL-17, (c) IL-12/IL-23 p40, and (d) IL-10. The amounts of IL-10 measured in supernatants of
IL-10-/- cells are equivalent to the assay background. Results shown are mean ± SD of
cytokines in triplicate cultures and are representative of three independent experiments.
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Cytokine production from co-cultures of CD4+ T lymphocytes isolated from MLN of either
colitic mice (GF→SPF IL-10-/- CD4+ MLN cells, grey bars) or noncolitic mice (SPF 129 wild
type CD4+ MLN cells, white bars) stimulated by cecal bacterial lysate-pulsed APC (APC only,
black bars). APC were obtained from either noncolitic mice (GF 129, GF IL-10-/-, SPF 129)
or from colitic mice (SPF IL-10-/-). Triplicate supernatants were harvested at day 3 and assayed
by ELISA for (a) IFNγ, (b) IL-17, (c) IL-12/IL-23 p40, and (d) IL-10. Results shown are mean
± SD of cytokines in triplicate cultures and are representative of four independent experiments.
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Cytokine production by APC pulsed with either control protein KLH (black bars) or cecal
bacterial lysate (CBL, white bars) and co-cultured with CD4+ T lymphocytes from colitic mice
(GF→SPF IL-10-/-) or recombinant murine IFNγ (0.4, 4, or 40 ng/ml) (a) and (c) or anti-IFN-
γ antibody (white bars) or isotype control antibody (black bars) at 50, 100, 500, or 2500 ng/ml
(b). Triplicate supernatants were harvested at day 3 and assayed by ELISA for (a) IL-10
secretion by 129 wild type APC co-cultured with IL-10-/- CD4+ cells or recombinant IFN-γ,
(b) IL-10 secretion by 129 wild type APC co-cultured with IL-10-/- CD4+ T cells in the
presence of either anti-IFN-γ antibody or isotype control antibody, and (c) IL-12/IL-23 p40
secretion by IL-10-/- APC co-cultured with IL-10-/- CD4+ cells or recombinant IFN-γ. Results
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shown are mean ± SD of cytokines in triplicate cultures and are representative of three
independent experiments.
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T cell depleted SPF 129 and IL-10-/- APC were either (X) enriched for B220+ cells by negative
selection of CD11b and CD11c cells using MACS, (Y) unfractionated after T cell depletion,
or (Z) enriched for CD11c+ by positive selection using MACS. The percentage of CD11c+
cells was determined by flow cytometry after overnight pulsing with cecal bacterial lysate and
is indicated in the figure below each set of bars for each population. B220+ enriched cells (X),
T cell depleted (Y), and CD11c+ enriched (Z) APC from both SPF 129 mice and SPF IL-10-/-
mice were co-cultured with CD4+ cells from noncolitic SPF 129 mice (black bars) or colitic
GF→SPF IL-10-/- mice (grey bars). Triplicate supernatants were harvested at day 3 and
assayed by ELISA for (a) IFNγ, (b) IL-17, (c) IL-12/IL-23 p40, and (c) IL-10. Results shown
are mean ± SD of cytokines in triplicate cultures and are representative of four independent
experiments.
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SPF 129 or IL-10-/- spleen cells were enriched for CD11c+ cells by cell sorting and co-cultured
with CD4+ cells from colitic GF→SPF IL-10-/- mice in the presence of KLH (black bars) or
cecal bacterial lysate (grey bars). Supernatants were harvested at day 3 and assayed by ELISA
for (a) IFNγ, (b) IL-17, and (c) IL-12/IL-23 p40. Results shown are mean ± SD of cytokines
in triplicate cultures and are representative of two independent experiments.
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Recombinant murine IL-10 (500 pg/ml, black bars; 50 pg/ml, white bars; or medium alone,
grey bars) was added to SPF IL-10-/- APC during the overnight pulse with cecal bacterial
lysate. The APC were washed and then additional IL-10 (500 or 50 pg/ml or medium) was
added for the duration of the 3 day co-culture with CD4+ T lymphocytes from GF→SPF
IL-10-/- colitic mice. Triplicate supernatants were harvested at day 3 and assayed by ELISA
for (a) IFNγ, (b) IL-17, and (c) IL-12/IL-23 p40. Results shown are mean ± SD of cytokines
in triplicate cultures and are representative of two independent experiments.
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Anti-IL-10 receptor antibody (black bars) or the isotype control, purified rat IgG1 (grey bars),
was added to SPF 129 APC at 30 μg/ml during the overnight pulse with cecal bacterial lysate.
The APC were washed and then additional anti-IL-10R or rat IgG1 at 30 μg/ml was added for
the duration of the 3 day co-culture of the 129 APC and IL-10-/- CD4+ T lymphocytes from
colitic mice. Triplicate supernatants were harvested at day 3 and assayed by ELISA for (a)
IFNγ, (b) IL-17, (c) IL-12/IL-23 p40, and (d) IL-10. Results shown are mean ± SD of cytokines
in triplicate cultures and are representative of two independent experiments.
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